Tier 4 — mechanistic

Alterations in glycine metabolism in obesity and chronic metabolic diseases - an update on new advances

Alves A, Morio B
Current opinion in clinical nutrition and metabolic care 2023 26(1):50-54

Bibliography

PubMed
PMID 36542534
Funding
Funding was not specified in the indexed abstract; the full funding disclosure has not been verified.
Competing interests
The accessible abstract does not establish the authors' competing interests; absence of a statement is not evidence of no conflicts.

Study snapshot

DesignNarrative review
ModelHuman and preclinical literature
SampleReview of newer obesity and metabolic-disease literature
InterventionGlycine availability, BCAA metabolism, weight loss and microbiota
DurationNot applicable; review
EndpointsCirculating glycine; Insulin resistance; Strategies to replenish glycine

What the study showed, in plain terms

This update emphasizes that glycine metabolism interacts with BCAA handling and weight loss. It explicitly leaves open whether dietary glycine effectively treats cardiometabolic disorders.

Key findings

  • Weight-loss strategies can replenish circulating glycine.
  • BCAA metabolism and microbiota may influence glycine availability.

What this study can and cannot tell us

Narrative evidence synthesis rather than a treatment trial.

Restoring a circulating amino-acid concentration is not equivalent to improving clinical outcomes.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified